Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Everist Health develops and commercializes non-invasive diagnostic tools for early detection of cardiovascular disease and personalized health risk assessment, including the AngioDefender system and the COVIDAge Risk Calculator. These products are used to inform individual health decisions and support physicians in early diagnosis before symptoms appear, aiming to improve outcomes and reduce healthcare costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Everist Health.